31 Results
Sort By:
Published on November 21, 2017
Researchers at Cardiff University in Wales have used the CRISPR/Cas9 gene editing technology to engineer killer T cells that are up to a thousand times more sensitive to cancer cell antigens than T cells engineered using more conventional approaches, and which allowed far better targeting of T cells to cancer…